Clinical trial
Evaluation of Long-term Efficacy of Treatment With Lamazym
NCT02478840 · Zymenex A/S, Industry · Completed
Key facts
| NCT number | NCT02478840 |
|---|---|
| Title | Evaluation of Long-term Efficacy of Treatment With Lamazym |
| Official title | A Single Center, Open Label Clinical Trial Investigating the Long-term Efficacy of rhLAMAN (Recombinant Human Alpha-mannosidase or Lamazym) Treatment in Subjects With Alpha-Mannosidosis Who Previously Participated in Lamazym Trials |
| Acronym | rhLAMAN-10 |
| Lead sponsor | Zymenex A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alpha-Mannosidosis |
| Intervention type | Drug |
| Interventions | Lamazym |
| Enrollment | 18 |
| Start date | Feb 1, 2015 |
| Primary completion | Jun 1, 2015 |
| Completion | Jun 1, 2015 |
| First posted | Jun 23, 2015 |
| Last update posted | Nov 20, 2020 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: